Angiogenesis
Scientists at Third Military Medical University discuss research in angiogenesis
Published in Cancer Weekly, July 28th, 2009
"Numerous evidences indicated that angiogenesis was a crucial step in the development of tumor, thus the immunotherapy of antiangiogenesis has been involved as potentially relevant candidate targets of cancer immunotherapy. Recently, tumor endothelial marker 8 (TEM8) was discovered to be dominantly expressed in tumor endothelium, which presented a new strategy to antiangiogenesis therapy," scientists writing in the Journal of Immunotherapy report.
"However, up to date, the related study of TEM8 on antiangiogenesis is very few. In this Study, we constructed a xenogenic DNA vaccine encoding human TEM8 carried by attenuated Salmonella typhimurium. The results...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-07-28)
More Articles from Cancer Weekly
- AngioDynamics, Inc.
AngioDynamics Reports Fiscal Fourth Quarter and Full Year 2009 Financial Results - Angiotensins
Exforge HCT® the only 3-in-1 single pill high blood pressure therapy shown more effective than dual combinations of its components - Breast Cancer
Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer - Breast Cancer
Possible Drug Target Found for One of the Most Aggressive Breast Cancers - Cancer
Researchers draft 3-D protein map to aid stroke, cancer research - Cancer
Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
